Sirpa Jalkanen

Sirpa Jalkanen (born 28 February 1954) is a Finnish scientist, working in the field of biomedical and clinical medicine, at the University of Turku in Finland.[1]

Sirpa Jalkanen
Born (1954-02-28) February 28, 1954
Jyväskylä, Finland
Alma materUniversity of Turku
Scientific career
FieldsBiomedical sciences
InstitutionsUniversity of Turku

Career

Jalkanen was born in Jyväskylä, Finland.[2] She is one of the world’s leading researchers in the area of lymphocyte migration in the human immune defence system.[3] Jalkanen is an Academy Professor (2014-) in the Academy of Finland.[2] She has served as Academy Professor on two previous occasions, in 1996–2001 and 2002–2006. During her term as Academy Professor, the focus of Professor Jalkanen’s research is on the mechanisms controlling the movement of cells in and out of lymph nodes. Her research is conducted as part of the Strategic Centre for Science, Technology and Innovation SalWe.[3] She is a member of Finnish Academy of Science and Letters.[4] In 2008, she was awarded the Matti Äyräpää Prize.[5]

References
  1. Kaiser, Robert G. (25 September 2005). "Why can't we be more like Finland?". The Seattle Times. Archived from the original on 13 March 2018. Sirpa Jalkanen, a microbiologist and biotech entrepreneur affiliated with Turku University in that ancient Finnish port city, told me she was discouraged by 'this new generation we have now who love entertainment, the easy life.'
  2. "Jalkanen, Sirpa" (PDF). Academy of Finland. Retrieved 2015-10-05.(in English)
  3. "Jalkanen, Sirpa". Academy of Finland. Archived from the original on 2015-10-06. Retrieved 2015-10-05.(in English)
  4. "Members of the Finnish Academy of Science and Letters". Academy of Finland. Archived from the original on 2015-10-07. Retrieved 2015-10-05.(in English)
  5. "Matti Äyräpään palkinto". Archived from the original on April 1, 2015. Retrieved 2016-09-09.CS1 maint: bot: original URL status unknown (link)
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.